Recent

% | $
Quotes you view appear here for quick access.

MannKind Corp. Message Board

  • redhaw_2000 redhaw_2000 Aug 16, 2014 4:28 PM Flag

    The selloff of regn 3/31/03 over a SEC document over novarits??

    Sad but true. From 20 to 6.5 in a day. Maybe there accounting was off. lol

    roiresearch • Mar 31, 2003 9:45 AM Flag

    0
    users liked this posts

    users disliked this posts
    0
    Reply

    3/28/03
    .

    Regeneron and Novartis Form Strategic Collaboration to Develop and Commercialize the IL-1 Trap in Rheumatoid Arthritis and Other Indications

    Novartis to Pay Regeneron $27 Million and Will Make $48 Million Equity Investment in Regeneron

    Novartis to Provide 100% Funding for Clinical Development and Provide Manufacturing Facility for Commercial Product Needs

    Companies Will Have Co-promotion Rights and Will Share Profits Equally in Europe and North America

    Companies May Broaden the Collaboration to Additional Pre-clinical or Early Development IL-1 Antagonists

    3/28/2003

    Tarrytown, NY � March 28, 2003 � Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced today that it has signed a development and commercialization agreement with Novartis AG covering Regeneron�s IL-1 Trap, a novel therapeutic candidate that blocks the activity of Interleukin-1 (IL-1). The IL-1 Trap is currently in Phase II clinical development for the treatment of rheumatoid arthritis.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
MNKD
0.6145-0.0664(-9.75%)Sep 23 4:00 PMEDT